Antidepressant treatment is associated with a reduction in suicidal ideation and suicide attempts

被引:29
作者
Mulder, R. T. [1 ]
Joyce, P. R. [1 ]
Frampton, C. M. A. [1 ]
Luty, S. E. [1 ]
机构
[1] Univ Otago, Dept Psychol Med, Christchurch Mail Ctr, Christchurch, New Zealand
关键词
antidepressants; suicide behaviours; depression;
D O I
10.1111/j.1600-0447.2008.01179.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To measure changes in suicidal behaviours during 6 months of treatment with antidepressants. Method: A group of depressed patients (n = 195) were assessed for suicidal behaviours in the 6 months prior to treatment. They were prospectively assessed for suicidal behaviours during 6 months of treatment with antidepressants. Results: Patients who made suicide attempts fell from 39 in the 6 months prior to treatment to 20 during treatment. Significant suicidal ideation reduced from 47% at baseline to 14% at 3 weeks remaining below this during the rest of the treatment. Twenty patients had emergent suicidal ideation; five of them had not experienced some level of suicidal behaviour in the 6 months prior to treatment. Conclusion: Suicide behaviours are common in depressed out-patients. Antidepressant treatment is associated with a rapid and significant reduction in suicidal behaviours. The rate of emergent suicidal behaviour was low and the risk benefit ratio for antidepressants appears to favour their use.
引用
收藏
页码:116 / 122
页数:7
相关论文
共 17 条
[1]   Suicidal risk in antidepressant drug trials [J].
Baldessarini, RJ ;
Pompili, M ;
Tondo, L .
ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (03) :246-248
[2]  
Beautrais AL, 2006, AUST NZ J PSYCHIAT, V40, P896, DOI 10.1111/j.1440-1614.2006.01909.x
[3]   Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials [J].
Fergusson, D ;
Doucette, S ;
Cranley, K ;
Glass, KC ;
Shapiro, S ;
Healy, D ;
Hebert, P ;
Hutton, B .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7488) :396-399
[4]  
Guy W., 1976, Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology-Revised. Rockville, MD, U.S. Department of Health, Education, and Welfare, Public health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, DHEW Publ No ADM 76-338, pp 218-222., P218
[5]   A RATING SCALE FOR DEPRESSION [J].
HAMILTON, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62
[6]   Suicidality in pediatric patients treated with antidepressant drugs [J].
Hammad, TA ;
Laughren, T ;
Racoosin, J .
ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (03) :332-339
[7]   Increased antidepressant use and fewer suicides in Jamtland county, Sweden, after a primary care educational programme on the treatment of depression [J].
Henriksson, S. ;
Isacsson, G. .
ACTA PSYCHIATRICA SCANDINAVICA, 2006, 114 (03) :159-167
[8]   Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline [J].
Joyce, PR ;
Mulder, RT ;
Luty, SE ;
Sullivan, PF ;
McKenzie, JM ;
Abbott, RM ;
Stevens, IF .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2002, 36 (03) :384-391
[9]   Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: Analysis of FDA reports [J].
Khan, A ;
Khan, S ;
Kolts, R ;
Brown, WA .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (04) :790-792
[10]   ACNP task force report on SSRIs and suicidal behavior in youth [J].
Mann, JJ ;
Emslie, G ;
Baldessarini, RJ ;
Beardslee, W ;
Fawcett, JA ;
Goodwin, FK ;
Leon, AC ;
Meltzer, HY ;
Ryan, ND ;
Shaffer, D ;
Wagner, KD .
NEUROPSYCHOPHARMACOLOGY, 2006, 31 (03) :473-492